Report on the risk assessment of 2-(methylamino)-1-(3-methylphenyl)propan-1-one (3-methylmethcathinone, 3-MMC) in accordance with Article 5c of Regulation (EC) No 1920/2006 (as amended) 17. Březen 2022, rubrika EUDA news
2. Červen 2026 Portuguese Minister of Health visits EUDA to discuss emerging drug-related challenges and European cooperation The European Union Drugs Agency (EUDA) welcomed the Portuguese Minister of Health, Dra Ana Paula Martins, together with ICAD...
